Found 281 matching trials
Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas N/A Head and neck squamous cell carcinoma (HNSCC) represents a significant publ...
Show More Location
Bangabandhu Sheikh Mujib Medical University (BSMMU)
Learn More & Join Trial
PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC N/A Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare condition ...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. N/A Circulating free cell DNA (cfDNA) is extracellular fragmentation of nucleic...
Show More Location
Stanford Genome Technology Center
Learn More & Join Trial
Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early Detection N/A Validation of biomolecular markers in the circulation and radiomic features...
Show More Location
Istituto Clinico Humanitas
Learn More & Join Trial
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China N/A To evaluate the concordance of sensitizing mutations detected between paire...
Show More Location
The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies NA An open non-randomized study using biology driven selection of therapies. W...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis PHASE2 This study is trying to evaluate the efficacy and safety of dose-modified E...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis N/A Background:
Drug resistant tuberculosis is a serious public health problem...
Show More Location
Multiple Locations
Learn More & Join Trial
Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA PHASE2 Treatment efficacy of osimertinib will be assessed in patients with lung ca...
Show More Location
Chonnam National University Hwasun Hospital
Learn More & Join Trial
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation PHASE2 The primary objective is to assess the activity and efficacy of pembrolizum...
Show More Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Learn More & Join Trial